493 related articles for article (PubMed ID: 24386144)
1. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
[TBL] [Abstract][Full Text] [Related]
2. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Jiang R; Cai XY; Yang ZH; Yan Y; Zou X; Guo L; Sun R; Luo DH; Chen QY; Huang PY; Xiang YQ; Lu X; Wang L; Xia WX; Mai HQ; Chen MY
Chin J Cancer; 2015 Jun; 34(6):237-46. PubMed ID: 26067059
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
[TBL] [Abstract][Full Text] [Related]
4. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
[TBL] [Abstract][Full Text] [Related]
5. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
7. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Low Lymphocyte-to-Monocyte Ratio Predicts Poor Clinical Outcomes for Patients with Urothelial Carcinoma of the Upper Urinary Tract.
Zhang XK; Yang P; Zhang ZL; Hu WM; Cao Y
Urol J; 2018 Nov; 15(6):348-354. PubMed ID: 30033515
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
10. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.
Lin GN; Peng JW; Liu DY; Xiao JJ; Chen YQ; Chen XQ
Tumour Biol; 2014 Nov; 35(11):10849-54. PubMed ID: 25081376
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
12. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.
Ni XJ; Zhang XL; Ou-Yang QW; Qian GW; Wang L; Chen S; Jiang YZ; Zuo WJ; Wu J; Hu X; Shao ZM
PLoS One; 2014; 9(11):e111886. PubMed ID: 25372468
[TBL] [Abstract][Full Text] [Related]
13. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma.
Gao P; Peng W; Hu Y
Head Neck; 2022 Mar; 44(3):624-632. PubMed ID: 35050540
[TBL] [Abstract][Full Text] [Related]
16. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.
Zhang W; Chen Y; Zhou G; Liu X; Chen L; Tang L; Mao Y; Sun Y; Ma J
Medicine (Baltimore); 2015 Sep; 94(37):e1505. PubMed ID: 26376394
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
Chua ML; Tan SH; Kusumawidjaja G; Shwe MT; Cheah SL; Fong KW; Soong YL; Wee JT; Tan TW
Eur J Cancer; 2016 Nov; 67():119-129. PubMed ID: 27640138
[TBL] [Abstract][Full Text] [Related]
20. Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.
Mo Y; Zhang B; Pan Y; Qin Q; Ye Y; Li X; Huang L; Jiang W
Oral Oncol; 2021 May; 116():105258. PubMed ID: 33706048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
